Clinical Trial
Accepted on 04 May 2026
Efficacy of 12-week treatment with Polyethylene glycol loxenatide in obesity or overweight patients with type 2 diabetes: a multicenter, prospective cohort study based on the flash glucose monitoring system
in Clinical Diabetes